The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126804031 12680403 1 I 20160816 20160824 20160824 EXP US-GLAXOSMITHKLINE-US2016GSK121750 GLAXOSMITHKLINE 0.00 F Y 0.00000 20160824 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126804031 12680403 1 PS POTIGA EZOGABINE 1 250 MG, TID U 22345 250 MG TID
126804031 12680403 2 SS POTIGA EZOGABINE 1 250 MG, TID U 22345 250 MG TID
126804031 12680403 3 SS Morphine MORPHINE 1 U 0
126804031 12680403 4 SS TORADOL KETOROLAC TROMETHAMINE 1 U 0
126804031 12680403 5 SS CECLOR CEFACLOR 1 U 0
126804031 12680403 6 SS DURICEF CEFADROXIL 1 U 0
126804031 12680403 7 SS NEURONTIN GABAPENTIN 1 0
126804031 12680403 8 SS TOPAMAX TOPIRAMATE 1 U 0
126804031 12680403 9 SS LIDOCAINE. LIDOCAINE 1 U 0
126804031 12680403 10 SS TRAMADOL. TRAMADOL 1 U 0
126804031 12680403 11 C NORCO ACETAMINOPHENHYDROCODONE BITARTRATE 1 0
126804031 12680403 12 C VALIUM DIAZEPAM 1 0
126804031 12680403 13 C ZANAFLEX TIZANIDINE HYDROCHLORIDE 1 0
126804031 12680403 14 C ELAVIL AMITRIPTYLINE HYDROCHLORIDE 1 0
126804031 12680403 15 C LASIX FUROSEMIDE 1 0
126804031 12680403 16 C VITAMIN B2 RIBOFLAVIN 1 0
126804031 12680403 17 C HYDROCODONE HYDROCODONE 1 0
126804031 12680403 18 C STADOL BUTORPHANOL TARTRATE 1 0 NASAL SPRAY
126804031 12680403 19 C LORTAB (ACETAMINOPHEN + HYDROCODONE) 2 0
126804031 12680403 20 C METHOCARBAMOL. METHOCARBAMOL 1 0
126804031 12680403 21 C LIDODERM LIDOCAINE 1 0
126804031 12680403 22 C COLACE DOCUSATE SODIUM 1 0
126804031 12680403 23 C PEPCID FAMOTIDINE 1 0
126804031 12680403 24 C CLEOCIN CLINDAMYCIN PHOSPHATE 1 0
126804031 12680403 25 C MIRALAX POLYETHYLENE GLYCOL 3350 1 0
126804031 12680403 26 C MILK OF MAGNESIA MAGNESIUM HYDROXIDE 1 0
126804031 12680403 27 C ALUMINUM HYDROXIDE+MAGNESIUM HYDROXIDE+SIMETHICONE 2 0
126804031 12680403 28 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 0
126804031 12680403 29 C CATAPRES CLONIDINE HYDROCHLORIDE 1 0
126804031 12680403 30 C CLARITIN LORATADINE 1 0
126804031 12680403 31 C Cepacol lozenge 2 0 LOZENGE
126804031 12680403 32 C PHENERGAN PROMETHAZINE HYDROCHLORIDE 1 0
126804031 12680403 33 C FLEXERIL CYCLOBENZAPRINE HYDROCHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126804031 12680403 1 Seizure
126804031 12680403 3 Product used for unknown indication
126804031 12680403 4 Product used for unknown indication
126804031 12680403 5 Product used for unknown indication
126804031 12680403 6 Product used for unknown indication
126804031 12680403 8 Product used for unknown indication
126804031 12680403 9 Product used for unknown indication
126804031 12680403 10 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126804031 12680403 HO
126804031 12680403 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126804031 12680403 Arthrodesis
126804031 12680403 Back pain
126804031 12680403 Burning sensation
126804031 12680403 Discomfort
126804031 12680403 Drain placement
126804031 12680403 Drug hypersensitivity
126804031 12680403 Endocrine disorder
126804031 12680403 Foraminotomy
126804031 12680403 Grip strength decreased
126804031 12680403 Hypoaesthesia
126804031 12680403 Immune system disorder
126804031 12680403 Injury
126804031 12680403 Intervertebral disc protrusion
126804031 12680403 Medical device implantation
126804031 12680403 Muscle spasms
126804031 12680403 Muscular weakness
126804031 12680403 Neck pain
126804031 12680403 Nerve block
126804031 12680403 Nerve compression
126804031 12680403 Nervous system disorder
126804031 12680403 Pain in extremity
126804031 12680403 Procedural nausea
126804031 12680403 Procedural vomiting
126804031 12680403 Pruritus
126804031 12680403 Pseudarthrosis
126804031 12680403 Rash
126804031 12680403 Reflex test abnormal
126804031 12680403 Respiratory arrest
126804031 12680403 Sensory loss
126804031 12680403 Spinal decompression
126804031 12680403 Spinal laminectomy
126804031 12680403 Spinal pain
126804031 12680403 Tenderness
126804031 12680403 Visual acuity reduced

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126804031 12680403 1 20130708 0
126804031 12680403 2 20140121 0